Lixte Biotechnology
LIXT
LIXT
11 hedge funds and large institutions have $4.43M invested in Lixte Biotechnology in 2021 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
Holders
11
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$225K | |
| 2 | +$154K | |
| 3 | +$151K | |
| 4 |
State Street
Boston,
Massachusetts
|
+$102K |
| 5 |
BlackRock
New York
|
+$13.1K |
Top Sellers
| 1 | -$182K | |
| 2 | -$43.2K | |
| 3 | -$35K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$5K |